# Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease

> **NCT04509219** · PHASE1 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Mucocutaneous Lymph Node Syndrome

## Interventions

- **DRUG:** Methylprednisolone Injection

## Key facts

- **NCT ID:** NCT04509219
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-15
- **Primary completion:** 2021-04-15
- **Final completion:** 2023-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04509219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04509219, "Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04509219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*